STAT

STAT+: Pharmalittle: Biogen to start large trial to confirm Alzheimer’s drug benefits; FDA to decide on easier access to abortion pill

Biogen expects to begin a large clinical trial next May to confirm the benefits of its Alzheimer’s treatment, pending clearance from the FDA.
Source: Alex Hogan/STAT

Top of the morning, and a fine one, it is. The sun is trying to break through clouds hovering over the Pharmalot campus, where

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Roche Obesity Drug, An Experimental Lilly Insulin, And More
Roche disclosed that its recently acquired experimental obesity medication helped people lose a significant amount of weight in a Phase 1 trial.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.

Related Books & Audiobooks